GKB Ophthalmics share news and announcements
NSE: GKBBSE: 533212Healthcare Equipment & SuppliesSmall Cap
Last close ₹59.54up ₹0.93 (1.59%)BSE ₹64.97
Share price at the NSE close on 23 Oct 2026. Previous close ₹58.61.
52-week range of BSE trades to 23 Oct 2026
₹45.25Low, 5 Dec 2025₹76.90High, 15 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹30 Cr3,821st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 9.3
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1.49 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 6.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 0.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.2%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1.49 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.21
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,45587.1% delivered
GKB Ophthalmics disputes and clarifications
14 filed, newest first.
Mar 2023
6 Mar · Legal
Exchange has sought clarification from GKB Ophthalmics Ltd on March 6, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Jan 2023
2 Jan · Legal
Exchange has sought clarification from GKB Ophthalmics Ltd on January 2, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Dec 2021
17 Dec · Legal
Exchange has sought clarification from GKB Ophthalmics Ltd on December 17, 2021, with reference to Movement in Volume. The reply is awaited.
Sep 2020
Nov 2019
13 Nov · Legal
Exchange has sought clarification from GKB Ophthalmics Ltd on 13th November, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Jul 2019
26 Jul · Legal
Exchange has sought clarification from the company on July 26, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Jan 2015
16 Jan · Legal
Price movement : Significant price movement has been observed in GKB Ophthalmics Limited.. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. GKB Ophthalmics Limited has vide its letter inter-alia stated, "There are no events or information which is pending with us that has bearing on the performance/operation of the Company, which has led to sudden increase in share price." (Source MSE)16 Jan · Legal
Price movement16 Jan · Legal
With reference to the Increase in Price, GKB Ophthalmics Ltd has Clarified to BSE as under : "There are no events or information which is pending with us that has bearing on the ....